Utility of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in the evaluation
of one-year outcomes of omalizumab treatment in severe allergic asthma
. Utility of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in the evaluation
of one-year outcomes of omalizumab treatment in severe allergic asthma. Alergologia Polska - Polish Journal of Allergology Special Issues. 2018.
APA
. (2018). Utility of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in the evaluation
of one-year outcomes of omalizumab treatment in severe allergic asthma. Alergologia Polska - Polish Journal of Allergology Special Issues.
Chicago
. 2018. "Utility of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in the evaluation
of one-year outcomes of omalizumab treatment in severe allergic asthma". Alergologia Polska - Polish Journal of Allergology Special Issues.
Harvard
. (2018). Utility of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in the evaluation
of one-year outcomes of omalizumab treatment in severe allergic asthma. Alergologia Polska - Polish Journal of Allergology Special Issues.
MLA
. "Utility of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in the evaluation
of one-year outcomes of omalizumab treatment in severe allergic asthma." Alergologia Polska - Polish Journal of Allergology Special Issues, 2018.
Vancouver
. Utility of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in the evaluation
of one-year outcomes of omalizumab treatment in severe allergic asthma. Alergologia Polska - Polish Journal of Allergology Special Issues. 2018.
This is an Open Access journal, all articles are distributed under the
terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC
BY-NC-SA
4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to
copy
and redistribute the material in any medium or format and to remix, transform, and build upon
the
material, provided the original work is properly cited and states its license.
